⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMPH News
Amphastar Pharmaceuticals, Inc.
Form 8-K
sec.gov
AMPH
Form 8-K
sec.gov
AMPH
IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight
globenewswire.com
NVS
VRTX
BIIB
VTRS
AZN
IONS
TAK
ARWR
BHVN
NVO
LLY
LXRX
XRTX
REGN
FMS
MDT
AMPH
DRCT
BMRC
MAZE
Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas
globenewswire.com
SGMO
LLY
AMPH
Pressure Sensor Market to Reach USD 18.6 Billion by 2031, Growing at 6.4% CAGR, Says Wissen Research
prnewswire.com
HON
STM
EMR
AMPH
S
INFY
Base10 Partners Hits $2.6B AUM, Closes $850M to Back the Next Wave of Real Economy AI
prnewswire.com
NU
AMPH
OPRA
Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
AMPH
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
globenewswire.com
AMPH
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
accessnewswire.com
AMPH
Form 8-K
sec.gov
AMPH